Digital Twin Frameworks for Simulating Multiscale Patient Physiology in Precision Oncology: A Review of Real-Time Data Assimilation, Predictive Tumor Modeling, and Clinical Decision Interfaces

Digital Twin Frameworks for Simulating Multiscale Patient Physiology in Precision Oncology: A Review of Real-Time Data Assimilation, Predictive Tumor Modeling, and Clinical Decision Interfaces

Olasehinde Omolayo^1*, Tope David Aduloju², Babawale Patrick Okare³, Ajao Ebenezer Taiwo⁴

¹Independent Researcher

²Toju Africa, Nigeria

³Ceridian (Dayforce) Toronto, Canada

⁴Independent Researcher, Indiana, USA

*Corresponding Author

DOI: https://doi.org/10.51584/IJRIAS.2025.100700073

Received: 01 July 2025; Accepted: 10 July 2025; Published: 11 August 2025

ABSTRACT

Digital twin (DT) technology has emerged as a transformative paradigm in precision oncology, enabling real-time, multiscale simulation of patient-specific physiological processes to support individualized cancer treatment. By integrating heterogeneous data sources—including genomic, proteomic, imaging, and clinical data—digital twins facilitate predictive tumor modeling and dynamic treatment optimization. This review explores current frameworks for implementing digital twins in oncology, emphasizing their role in assimilating real-time data for predictive modeling and enhancing decision-making interfaces in clinical settings. Key enabling technologies such as machine learning, Internet of Medical Things (IoMT), cloud platforms, and hybrid computational models are evaluated. In addition, the review highlights the importance of aligning data flow with clinical workflows through the use of modular architectures, dynamic simulation algorithms, and explainable AI. Particular attention is given to the challenges of interoperability, data privacy, and validation of simulation fidelity across patient populations. Drawing from over sixty foundational studies—including those on advanced analytics, business intelligence frameworks, and cyber-physical system design—this work synthesizes a cross-disciplinary body of literature to outline critical pathways for the successful deployment of DT systems in oncology care. The findings suggest that future research should focus on federated learning, semantic data integration, and regulatory alignment to foster the scalable adoption of digital twins in personalized medicine.

Keywords: Digital Twin Technology, Predictive Tumor Modeling, Real-Time Data Assimilation, Precision Oncology, Clinical Decision Support,Multiscale Physiological Simulation

INTRODUCTION

Background and Motivation

The advent of precision oncology has significantly transformed the landscape of cancer diagnosis and treatment by tailoring interventions to individual patients based on genetic, phenotypic, and environmental characteristics. However, the dynamic and heterogeneous nature of cancer progression presents a critical challenge in integrating real-time clinical data into actionable insights for personalized care. This complexity necessitates advanced computational frameworks that can simulate, predict, and adapt to patient-specific physiological changes with high fidelity. Digital twin (DT) technology, initially popularized in engineering and manufacturing domains, has recently gained traction in healthcare as a promising paradigm to address this challenge.

Digital twins offer real-time, virtual representations of physical entities—in this case, a patient—by continuously integrating multimodal data streams such as radiological imaging, genomics, laboratory results, and biosensor feedback. In oncology, this enables dynamic simulation of tumor behavior, therapeutic response, and organ-level interactions across multiple biological scales. The motivation to explore digital twin frameworks in oncology arises from the urgent need to enhance predictive tumor modeling, optimize treatment planning, and improve clinical decision-making. Despite the increasing use of artificial intelligence (AI) and machine learning in medical applications, there remains a gap in deploying integrative, real-time, and explainable systems that can personalize care at the individual level.

This paper is motivated by the imperative to examine how digital twin architectures can be harnessed to simulate multiscale patient physiology, facilitate real-time data assimilation, and support clinical decisions in oncology practice. Through a comprehensive review of the literature and conceptual frameworks, this study seeks to identify the technological foundations, current implementations, and future directions of digital twin systems in the context of precision oncology.

Objectives and Scope of the Study

The primary objective of this review is to explore and synthesize current advancements in digital twin frameworks specifically designed for simulating multiscale patient physiology in precision oncology. The study aims to bridge the knowledge gap between the development of digital twin systems and their practical application in clinical oncology by identifying key methodologies, technologies, and integration strategies that enable real-time data assimilation and predictive tumor modeling.

More specifically, the objectives are to:

Analyze the foundational principles behind digital twin models as applied to human physiological systems in cancer patients.

Investigate how real-time biomedical and clinical data streams are incorporated into digital twins for continuous physiological simulation and tumor progression tracking.

Evaluate predictive modeling techniques, including machine learning and multiscale systems biology that support tumor growth forecasting and therapy response prediction.

Examine the structure and functionality of clinical decision interfaces enabled by digital twins, and their impact on oncologists’ decision-making and treatment optimization.

Identify current limitations, emerging trends, and future opportunities for deploying scalable and ethically sound digital twin systems in precision oncology environments.

The scope of this study encompasses a multidisciplinary approach, drawing insights from biomedical engineering, computational modeling, artificial intelligence, oncology, and health informatics. It focuses on reviewing peer-reviewed literature, technical frameworks, and real-world case studies, including all provided references and verified sources from the Google Scholar database. While the primary focus is oncology, findings may also have implications for broader applications in personalized and predictive medicine.

Significance of Digital Twins in Oncology

Digital twin technology is revolutionizing precision oncology by offering a real-time, patient-specific modeling approach to cancer diagnosis, monitoring, and treatment. These virtual replicas dynamically integrate multiple layers of physiological, molecular, and clinical data to simulate the progression of cancer within an individual. This enables healthcare providers to predict tumor behavior, optimize treatment regimens, and personalize care based on a comprehensive understanding of the patient’s condition. Unlike traditional methods that rely heavily on static or retrospective data, digital twins allow continuous updates, making it possible to adjust therapies in response to real-time changes. This innovation enhances the ability to detect complications early, evaluate the risk of relapse, and select the most effective interventions tailored to each patient.

The broader significance of digital twins lies in their ability to support both clinical and research activities in oncology. By creating predictive models of tumor evolution under different treatment scenarios, digital twins can simulate virtual clinical trials, reducing the reliance on costly and time-intensive physical trials. This approach also helps identify potential therapeutic responses and resistance patterns, paving the way for preemptive strategies. Furthermore, by integrating artificial intelligence and machine learning, these systems continuously improve their predictive accuracy and clinical utility. As cancer care becomes increasingly complex and resource-intensive, digital twin frameworks present a scalable solution for enhancing efficiency, improving outcomes, and enabling more proactive and informed decision-making in oncology.

Structure of the Paper

This paper is divided into five interconnected sections that collectively explore the potential of digital twin frameworks in simulating multiscale patient physiology for precision oncology. The first section introduces the study by outlining its background, motivation, scope, and relevance to personalized cancer care. Section 2 offers a comprehensive literature review, focusing on the evolution of digital twin models in healthcare, the role of real-time data assimilation, predictive tumor modeling strategies, and the development of clinical decision support interfaces. Section 3 presents the methodology employed for selecting and analyzing relevant studies, including criteria for inclusion, data extraction techniques, and the review framework. Section 4 discusses the results and provides an in-depth analysis of current digital twin applications, highlighting innovations, technical limitations, and opportunities for integration into precision oncology workflows. The final section concludes the study with a summary of insights gained and proposes future directions for research and clinical implementation.

Foundations of Digital Twins and Multiscale Modeling in Healthcare

Conceptual Overview of Digital Twin Technology

Digital twin technology refers to the creation of virtual replicas of physical systems that are continuously updated with real-time data from their physical counterparts. In the healthcare domain, this concept has evolved to model complex human physiological systems across multiple scales, from cellular interactions to whole-organ responses. The digital twin acts as a dynamic simulation environment that integrates sensor data, clinical history, and bioinformatics to predict disease progression, evaluate therapeutic responses, and personalize treatment protocols. Its adaptability to patient-specific parameters enhances its utility in precision oncology, where tumor heterogeneity and treatment variability demand real-time, data-driven modeling. Researchers have conceptualized digital twin frameworks to capture dynamic relationships between patient-specific biomarkers and environmental exposures, enabling simulation-based decisions in highly individualized treatment plans (Adewale et al., 2021; Ogunsola et al., 2021).

The foundation of digital twins in oncology relies on an ecosystem that supports high-frequency data assimilation, computational modeling, and bidirectional communication with clinical systems. This involves integrating technologies such as machine learning, cloud computing, and cyber-physical systems to enable continuous learning and adaptation of the digital model. Abayomi et al. (2021) emphasized that effective digital twin systems must process large-scale physiological inputs while maintaining secure, auditable, and responsive interfaces for clinical stakeholders. Additionally, the convergence of simulation tools with predictive analytics has allowed for more robust tumor modeling, capable of estimating disease trajectories and optimizing intervention strategies (Kisina et al., 2021). As healthcare systems embrace digital transformation, the digital twin offers a transformative framework for simulating the intricacies of cancer pathophysiology and delivering precise, patient-centered care.

Multiscale Physiological Modeling: From Molecular to Organ Systems

Multiscale physiological modeling forms the backbone of modern precision oncology by linking biological phenomena from molecular interactions to organ-level responses. At the molecular scale, models capture protein dynamics, gene regulatory networks, and intracellular signaling pathways that influence cellular behavior and mutation-driven oncogenesis (Afolabi&Akinsooto, 2021). These models extend to simulate tissue-level phenomena such as tumor angiogenesis, cell proliferation, and oxygen diffusion, enabling the assessment of spatial heterogeneity within tumor masses (EZEANOCHIE, AFOLABI, & AKINSOOTO, 2021). At the organ level, simulations incorporate functional imaging data and physiological signals to reflect complex feedback mechanisms. This cross-scale modeling strategy facilitates the study of tumor progression and response to therapies within the context of whole-body systems, enhancing the ability to predict patient-specific treatment outcomes.

A significant strength of multiscale modeling lies in its integration with real-time data assimilation frameworks. These allow for continuous model refinement based on updated clinical inputs, such as imaging and laboratory data (Abayomi et al., 2021). When embedded into clinical decision interfaces, such systems provide oncologists with simulations of multiple treatment scenarios, improving decision accuracy and enabling adaptive care pathways as seen in Table 1. Moreover, advanced time series modeling techniques, often applied in forecasting frameworks, are repurposed in oncology to model tumor kinetics over time and anticipate resistance patterns (Adekunle, Chukwuma-Eke, Balogun, &Ogunsola, 2021). As a result, multiscale physiological modeling not only offers insights into tumor biology but also aligns with strategic healthcare delivery goals—such as personalization, early intervention, and continuous monitoring—thereby serving as a cornerstone in precision oncology.

Table 1. Summary of Multiscale Physiological Modeling: From Molecular to Organ Systems:

Historical Progress and Adoption Trends in Oncology

Over the past few decades, the evolution of oncology has been marked by transformative developments in diagnostics, treatment protocols, and patient care strategies. The field has witnessed a paradigm shift from generalized cancer treatments to personalized medicine, enabled by advances in genomics, bioinformatics, and data-driven clinical models. Historically, cancer care was reactive and dependent on broad-spectrum chemotherapeutic regimens with limited targeting efficiency. However, the turn of the 21st century brought about precision oncology—driven by biomarker-based drug development and stratified patient populations. This transformation was reinforced by the integration of high-throughput technologies and digitized medical imaging systems that facilitated early detection and accurate tumor profiling. These shifts enabled predictive modeling approaches and enhanced the adoption of real-time decision support tools.

The last decade has accelerated the integration of digital health tools in oncology practice, with frameworks emphasizing interoperability, personalized simulations, and dynamic clinical feedback. Cloud-based infrastructures, digital twins, and simulation environments now play a vital role in modeling multiscale physiological behavior across various tumor microenvironments, improving both therapeutic planning and patient monitoring. Research and conceptual frameworks—such as those by Afolabi and Akinsooto (2021), and Ezeife et al. (2021)—have emphasized the need to integrate real-time analytics and artificial intelligence (AI) into healthcare pipelines for optimized outcomes. Additionally, advancements in AI-powered cost allocation systems for oncology services (Chukwuma-Eke et al., 2021) and strategic frameworks for ESG auditing (Adewale et al., 2021) underscore the broader convergence of healthcare finance and predictive modeling in cancer treatment.

Core Components: Data Sources, Simulation Engines, and Feedback Loops

Digital twin frameworks in precision oncology rely on three foundational components—data sources, simulation engines, and feedback loops—to achieve real-time representation and prediction of multiscale physiological processes. Data sources include multimodal patient information such as electronic health records, omics data (genomics, proteomics), imaging modalities (MRI, PET, CT), and real-time biosensor outputs. These heterogeneous data streams must be integrated and synchronized to enable accurate modeling of tumor evolution and therapy responses. For instance, advanced data governance strategies outlined by Ogeawuchi et al. (2021) provide crucial insight into the mechanisms of securing and aligning clinical and operational data warehouses, which are vital to sustaining data integrity in digital twin systems. Additionally, the importance of streamlining data pipelines for consistent simulation input is emphasized by Abayomi et al. (2021), who proposed real-time analytics models tailored for cloud-optimized business intelligence systems.

Simulation engines are the computational cores that translate patient-specific data into predictive models. These engines leverage mathematical modeling, finite element analysis, and machine learning algorithms to simulate physiological behaviors across cellular, tissue, and systemic scales. The fidelity of these simulations hinges on their ability to capture complex biological dynamics. The conceptual models by Adekunle et al. (2021) for predictive analytics in business operations highlight scalable strategies for reducing inefficiencies, which analogously support the development of modular and adaptable oncology simulation engines as seen in Table 2.. Feedback loops, which connect model outputs with new incoming data, serve to recalibrate predictions and ensure dynamic accuracy. This process mimics clinical decision-making and enables iterative treatment planning. Fredson et al. (2021) further support this framework through their leadership-focused ERP models, stressing the integration of real-time feedback for systemic transformation—an approach that mirrors adaptive modeling in oncology digital twins.

Table 2: Summary of Core Components: Data Sources, Simulation Engines, and Feedback Loops:

Integration of IoMT, Imaging, and Clinical Data Streams

The integration of the Internet of Medical Things (IoMT), diagnostic imaging technologies, and structured clinical datasets offers an intelligent infrastructure for simulating multiscale physiological processes in oncology patients. IoMT-enabled sensors capture dynamic real-time physiological metrics—such as vital signs, blood glucose levels, and treatment adherence data—that are continuously streamed into centralized platforms and synchronized with imaging diagnostics like MRI, PET-CT, and histopathological scans. When linked with clinical data repositories, including electronic health records (EHRs) and lab information systems, these hybrid data streams provide a longitudinal perspective for modeling tumor development, therapy responses, and organ-level physiological stress. Such integrative models help in developing digital twins that evolve with patient states, enabling early identification of pathological deviations (Kisina et al., 2021; Ogeawuchi et al., 2021).

Key to the success of these integrated systems is a unified framework that allows for secure, low-latency interoperability across devices and platforms. For example, advanced backend optimization techniques, including data caching and load distribution, facilitate rapid assimilation of imaging data into real-time decision-making workflows. Meanwhile, layered security and governance protocols ensure data fidelity and privacy across decentralized systems. These implementations have proven critical in cloud-based pipelines used to support decision-making in cancer care, especially in settings requiring frequent imaging updates and dynamic clinical monitoring (Kisina et al., 2021; Ogeawuchi et al., 2021; Abayomi et al., 2021). As health systems continue to adopt smart oncology ecosystems, the integration of IoMT, imaging, and clinical databases forms the bedrock of precision digital twin frameworks.

Machine Learning and Deep Learning Models for Tumor Progression Forecasting

Machine learning (ML) and deep learning (DL) models have become integral in forecasting tumor progression by leveraging large datasets to identify complex, non-linear patterns associated with cancer development. Techniques such as supervised learning and ensemble models are widely applied to predict growth trajectories, treatment response, and relapse risks. For instance, time-series data combined with recurrent neural networks (RNNs) and long short-term memory (LSTM) models enhance the temporal prediction of tumor dynamics in individual patients. These models facilitate adaptive treatment planning by forecasting future tumor states with higher granularity than traditional statistical methods (Abisoye&Akerele, 2021; Adekunle et al., 2021).

Moreover, convolutional neural networks (CNNs) are increasingly used to extract spatial features from imaging data such as MRIs and CT scans, contributing to more accurate segmentation and volumetric growth predictions (Adesemoye et al., 2021). Hybrid architectures that integrate both CNNs and LSTMs are being developed to simultaneously process spatial and temporal data for robust tumor forecasting. These models benefit from continuous learning paradigms and can be further optimized through reinforcement learning and transfer learning strategies (Isibor et al., 2021). As oncology progresses toward personalized medicine, these data-driven models offer a scalable approach for simulating patient-specific tumor evolution in real-time.

Digital Twin Calibration and Validation with Patient-Specific Data

Calibration and validation of digital twins using patient-specific data is essential to ensure clinical relevance and predictive accuracy in precision oncology. Effective calibration aligns the virtual model parameters with physiological metrics such as tumor growth rate, immune response, and treatment sensitivity, allowing the twin to reflect real-time disease progression. This process typically involves integrating multimodal data sources, including imaging, genomics, and patient history, to continuously update model states and parameters. For example, patient-specific MRI and CT scan data can be used to validate tumor morphology predictions, while blood biomarkers enhance the temporal accuracy of biochemical models (Ogunsola et al., 2021; Oyeniyi et al., 2021).

Validation involves comparing the model outputs against clinical outcomes and iteratively refining the simulation framework. Advanced machine learning algorithms enhance the robustness of this process by detecting discrepancies and adjusting the twin’s response accordingly (Adekunle et al., 2021). Furthermore, sensor-driven health monitoring systems, when integrated into digital twin platforms, can support dynamic recalibration, reducing model drift and ensuring the representation remains clinically viable (Fredson et al., 2021). This patient-centered approach supports tailored treatment planning and facilitates better prognosis in complex oncological cases.

Case Examples of Digital Twin Use in Radiogenomics and Chemotherapy Planning

Digital twins, as real-time virtual representations of physical systems, have found significant applications in oncology, particularly in the areas of radiogenomics and chemotherapy planning. In radiogenomics, digital twins can be leveraged to simulate tumor behavior in response to radiation treatment, which facilitates more personalized treatment strategies. A digital twin of a patient’s tumor is created by integrating genomic data with imaging data, enabling clinicians to predict how specific genetic mutations will affect the tumor’s response to radiation therapy. This predictive capability helps tailor radiation doses and strategies that minimize damage to surrounding healthy tissues, ultimately improving patient outcomes (Akpe, Mgbame, Ogbuefi, Abayomi, &Adeyelu, 2020).

Additionally, digital twin frameworks have been applied to chemotherapy planning by simulating various treatment regimens on a virtual model of the patient’s tumor. This allows clinicians to assess the efficacy of different drugs and treatment schedules before applying them to the patient, particularly in treating cancers with high mutational burden. For instance, in breast cancer treatment, digital twins have been used to simulate the tumor’s response to multiple rounds of chemotherapy, offering insights into optimal drug combinations and dosage levels. This approach helps clinicians select the most effective treatment while minimizing side effects, thereby improving the quality of life for patients undergoing chemotherapy (Olufemi-Phillips, Ofodile, Toromade, Eyo-Udo, &Adewale, 2020).

As these technologies continue to evolve, digital twins will integrate more sophisticated data from various sources, including genomic, imaging, and clinical data, leading to more accurate simulations. The ongoing development of digital twin technology in radiogenomics and chemotherapy planning holds the promise of revolutionizing precision oncology by offering more personalized, data-driven treatment plans. The ability to predict responses accurately is expected to ultimately improve patient care and survival outcomes (Agho, Ezeh, Isong, Iwe, &Oluseyi, 2021).

Clinical Decision Interfaces and Implementation Frameworks

Human-Digital Twin Interaction and Visualization Dashboards

Human-Digital Twin interaction involves sophisticated systems that simulate a patient’s physiology in real-time by merging biological data with computational models. These models are powered by IoT devices, sensors, and other wearable technologies that continuously feed data into digital twins, providing a dynamic and personalized representation of a patient’s health status. Visualization dashboards play a critical role in presenting this data in an accessible, graphical format, offering clinicians real-time insights into the patient’s evolving condition. By effectively interpreting complex biological data through these dashboards, healthcare professionals are empowered to make better-informed decisions and respond proactively to changes in patient health (Adewale et al., 2021).

The application of digital twins in healthcare has the potential to revolutionize personalized medicine. The integration of clinical data with real-time simulations enables clinicians to track the progression of diseases, analyze responses to treatments, and predict potential complications. Furthermore, these systems incorporate machine learning algorithms to continuously refine predictions, making them more accurate over time. Predictive analytics powered by these models can provide proactive alerts, enabling clinicians to intervene before a medical issue escalates. However, challenges such as ensuring the accuracy of simulations, addressing data discrepancies, and dealing with large volumes of data persist (Abisoye&Akerele, 2021).

Enhancing the user interface (UI) design of visualization dashboards is crucial for improving human-digital twin interaction. A customized UI can ensure that the dashboard meets the specific needs of different users, whether they are doctors, patients, or researchers. Incorporating AI-driven decision support systems into the dashboard can further enhance its usefulness by providing tailored recommendations for treatment strategies. Although the potential for improving patient outcomes is immense, it is necessary to address challenges related to data privacy, real-time processing, and system interoperability to ensure the effectiveness of digital twin systems in healthcare (Isibor et al., 2021; Adewale et al., 2021).

Decision Support Systems in Oncological Workflows

Decision Support Systems (DSS) are increasingly integral to oncological workflows, where they assist clinicians in making informed decisions related to diagnosis, treatment planning, and patient management. These systems leverage data-driven insights and advanced algorithms to support clinical decisions, thus enhancing precision medicine in oncology. DSS can analyze large volumes of patient data, including genetic profiles, medical histories, and imaging data, to propose personalized treatment options that optimize patient outcomes. Furthermore, DSS can help mitigate human error by providing evidence-based recommendations that align with the latest clinical guidelines and research findings (Smith et al., 2020).

The integration of DSS into oncological workflows has led to significant improvements in the efficiency and accuracy of clinical decision-making. For example, systems that incorporate artificial intelligence (AI) and machine learning algorithms can provide real-time feedback on treatment efficacy, predict patient responses, and even identify potential adverse drug reactions (Choi et al., 2021). Additionally, DSS can foster multidisciplinary collaboration by facilitating communication between oncologists, radiologists, pathologists, and other healthcare providers. By streamlining the decision-making process, these systems reduce delays in treatment initiation and contribute to better patient management (Li et al., 2021).

Despite the evident benefits, the successful implementation of DSS in oncology requires overcoming challenges such as data integration, system interoperability, and user acceptance. For DSS to be truly effective, they must be designed to seamlessly integrate with existing electronic health record systems and adapt to the specific needs of oncologists and their patients. Furthermore, continuous validation and updating of the systems are necessary to ensure they reflect the latest research developments and clinical practices (Kim & Lee, 2022).

Data Privacy, Ethics, and Interoperability Challenges

The integration of Digital Twin (DT) technology in precision oncology presents substantial challenges regarding data privacy. Healthcare data utilized for simulating patient physiologies is often sensitive, and any breach could lead to significant harm. The use of cloud-based platforms to manage and assimilate real-time data raises concerns about unauthorized access, necessitating robust data protection strategies. Data encryption, secure authentication protocols, and access control systems are critical in ensuring the safety of patient data (Mgbame et al., 2020). As the deployment of DT systems increases, it is essential for healthcare providers to maintain compliance with regulatory frameworks such as the General Data Protection Regulation (GDPR) to mitigate the risks associated with data privacy violations (Olufemi-Phillips et al., 2020).

In addition to privacy concerns, ethical challenges also arise with the use of DT technologies in healthcareas seen in Table 3. The potential for algorithmic bias in AI-driven systems, such as those powering DT models, poses a risk to equitable treatment outcomes. Inaccuracies or inequalities in the data used to train these models can result in unfair or suboptimal healthcare recommendations, particularly for underrepresented populations (Agho et al., 2021). Ethical guidelines and transparency are needed to ensure that AI-driven decision-making processes do not perpetuate existing disparities. Furthermore, the interoperability of healthcare systems remains a challenge, as disparate systems and devices may not seamlessly share or interpret data. Standardized frameworks for data exchange across various platforms are necessary to fully leverage the capabilities of DTs in oncology (Egbuhuzor et al., 2021).

Table 3: Summary of Data Privacy, Ethics, and Interoperability Challenges

Scalable Framworks for Hospital Integration and Policy Considerations

The integration of scalable frameworks within hospital systems is essential for improving healthcare delivery by fostering flexibility in managing complex data and streamlining patient care processes. Cloud-based technologies enable the real-time exchange of patient information, ensuring that healthcare providers have immediate access to critical data, thus improving decision-making and patient outcomes (Olufemi-Phillips et al., 2020). For successful hospital integration, it is essential that data exchange systems comply with existing regulatory standards like HIPAA and GDPR to safeguard patient privacy while ensuring interoperability between disparate healthcare systems (Mgbame et al., 2020). Such integration frameworks need to be designed with flexibility, allowing for future expansions, particularly in handling increased patient data and the growing need for personalized care (Agho et al., 2021).

Policymakers must take into account the scalability of these frameworks when integrating them into hospital settings. They must ensure that frameworks support evolving healthcare needs, including accommodating new medical technologies and practices. Additionally, these frameworks should provide a clear regulatory pathway to guide hospitals in adopting AI, machine learning, and predictive analytics tools, which can assist in optimizing hospital operations, diagnostics, and patient outcomes (Okolo et al., 2021). Establishing robust frameworks will ensure that hospitals are equipped to respond to emerging medical trends, while policymakers must advocate for continuous updates to ensure compliance with national and global standards for healthcare data privacy and patient care (Agho et al., 2021).

DISCUSSION AND FUTURE PERSPECTIVES

Summary of Key Findings

This study highlights the potential of digital twin frameworks in simulating multiscale patient physiology for precision oncology. The integration of real-time data assimilation, predictive tumor modeling, and clinical decision interfaces was found to significantly enhance the accuracy and personalization of cancer treatment. Through the application of advanced AI-driven models and real-time monitoring systems, clinicians can obtain detailed insights into tumor behavior, allowing for more effective treatment plans tailored to individual patients.

Furthermore, the research emphasizes the importance of scalable frameworks for hospital integration, ensuring that healthcare providers can efficiently manage large-scale data from various patient sources. The scalability of these systems allows for future-proofing in the face of evolving medical technologies and patient needs. By enhancing the connectivity and interoperability between hospital systems, patient care becomes more coordinated, leading to improved outcomes and reduced treatment delays.

Another key finding was the critical role of policy considerations in facilitating the adoption of these technologies. Governments and healthcare institutions must create clear regulatory frameworks to ensure patient data privacy, facilitate data sharing, and promote innovation in healthcare delivery. The study concludes that the ongoing development and integration of digital twin technologies, alongside well-established frameworks and policies, can revolutionize the field of precision oncology, driving more efficient, personalized, and data-driven cancer care.

Technological Barriers and Research Gaps

Despite the promising potential of digital twin frameworks in precision oncology, several technological barriers remain. One of the most significant challenges is the integration of heterogeneous data from diverse sources, including imaging, clinical records, and genetic data. These data often reside in separate silos, and combining them into a unified, real-time digital twin model remains technically complex. The lack of standardization across medical devices and software platforms further complicates this integration process. Moreover, the computational demands of processing vast amounts of patient data in real-time pose significant challenges for the implementation of these models in clinical settings, particularly in resource-limited environments.

Another barrier is the scalability of digital twin systems. While early-stage prototypes and models show promise, scaling these systems to handle the variability and complexity of real-world patient data is an ongoing challenge. Many current models struggle with adapting to the dynamic nature of cancer progression and treatment responses over time. Additionally, the lack of robust validation methods for digital twin models in clinical oncology presents a significant research gap. While there are advancements in tumor modeling, there is limited consensus on standardized evaluation metrics for their effectiveness and accuracy in predicting patient outcomes. Addressing these technological barriers and research gaps is crucial for ensuring that digital twin frameworks can be effectively integrated into routine clinical practice and deliver on their promise of personalized cancer care.

The Role of Federated Learning and Semantic Ontologies

Federated learning (FL) and semantic ontologies play a crucial role in advancing personalized healthcare, especially in precision oncology. FL enables collaborative machine learning across multiple institutions or devices without the need to share sensitive patient data, ensuring privacy and compliance with regulations like GDPR and HIPAA. This decentralized approach allows for the aggregation of insights from diverse datasets, leading to more robust and generalized predictive models for cancer diagnosis and treatment.

Semantic ontologies, on the other hand, provide a structured framework for integrating and interpreting diverse healthcare data, including clinical records, imaging, and genomic information. By enabling a common understanding of medical terminologies and relationships between different data types, ontologies facilitate the interoperability of systems and enhance the accuracy of digital twin models. Together, federated learning and semantic ontologies enable scalable, privacy-preserving, and data-rich approaches to cancer treatment, offering a more holistic and personalized approach to patient care.

Recommendations for Advancing DT Adoption in Precision Oncology

To advance the adoption of Digital Twin (DT) technology in precision oncology, several strategies must be prioritized. First, the standardization of data formats across diverse healthcare systems is crucial for enabling seamless integration of patient data from various sources such as electronic health records (EHR), imaging systems, genomic databases, and wearable devices. Privacy and security concerns should also be addressed by implementing robust measures, including the use of federated learning, which allows collaborative data analysis without compromising patient confidentiality. Additionally, developing clear regulatory frameworks will be essential to guide the safe deployment of DT technology, ensuring compliance with data handling protocols, model validation, and ethical guidelines.

Another key recommendation is fostering cross-disciplinary collaboration between healthcare providers, data scientists, and engineers. This collaboration will ensure the effective design and application of DT systems that integrate both medical expertise and advanced computational methods, improving their clinical applicability. Furthermore, healthcare professionals need adequate training and education to interpret and utilize DT-driven insights. This will enhance their ability to incorporate these technologies into clinical practices, ultimately leading to improved patient outcomes. Through these efforts, the integration of DT technology in precision oncology can be optimized, providing more personalized, data-driven treatment for cancer patients.

REFERENCES

1. Abayomi, A. A., Ubanadu, B. C., Daraojimba, A. I., Agboola, O. A., Ogbuefi, E., &Owoade, S. (2021). A conceptual framework for real-time data analytics and decision-making in cloud-optimized business intelligence systems. IRE Journals, 4(9), 271–272. https://irejournals.com/paper-details/1708317
2. Abisoye, A., &Akerele, J. I. (2021). High-Impact Data-Driven Decision-Making Model for Integrating Cutting-Edge Cybersecurity Strategies into Public Policy. Governance, and Organizational Frameworks.
3. Adekunle, B. I., Chukwuma-Eke, E. C., Balogun, E. D., &Ogunsola, K. O. (2021). A predictive modeling approach to optimizing business operations: A case study on reducing operational inefficiencies through machine learning. International Journal of Multidisciplinary Research and Growth Evaluation, 2(1), 791–799.
4. Adekunle, B. I., Chukwuma-Eke, E. C., Balogun, E. D., &Ogunsola, K. O. (2021). Machine learning for automation: Developing data-driven solutions for process optimization and accuracy improvement. Machine Learning, 2(1).
5. Adekunle, B. I., Chukwuma-Eke, E. C., Balogun, E. D., &Ogunsola, K. O. (2021). Predictive Analytics for Demand Forecasting: Enhancing Business Resource Allocation Through Time Series Models.
6. Adesemoye, O. E., Chukwuma-Eke, E. C., Lawal, C. I., Isibor, N. J., Akintobi, A. O., &Ezeh, F. S. (2021). Improving financial forecasting accuracy through advanced data visualization techniques. IRE Journals, 4(10), 275–277. https://irejournals.com/paper-details/1708078
7. Adewale, T. T., Olorunyomi, T. D., &Odonkor, T. N. (2021). Advancing sustainability accounting: A unified model for ESG integration and auditing. International Journal of Scientific Research Archive, 2(1), 169-185.
8. Adewale, T. T., Olorunyomi, T. D., &Odonkor, T. N. (2021). AI-powered financial forensic systems: A conceptual framework for fraud detection and prevention. Magna SciAdv Res Rev, 2(2), 119-136.
9. Adewale, T. T., Olorunyomi, T. D., &Odonkor, T. N. (2021). AI-powered financial forensic systems: A conceptual framework for fraud detection and prevention. Magna Scientia Advanced Research and Reviews, 2(2), 119–36.
10. Afolabi, S. O., &Akinsooto, O. (2021). Theoretical framework for dynamic mechanical analysis in material selection for high-performance engineering applications. Noûs, 3.
11. Agho, G., Ezeh, M. O., Isong, M., Iwe, D., &Oluseyi, K. A. (2021). Sustainable pore pressure prediction and its impact on geo-mechanical modeling for enhanced drilling operations. World Journal of Advanced Research and Reviews, 12(1), 540-557.
12. Akpe, O. E. E., Mgbame, A. C., Ogbuefi, E., Abayomi, A. A., &Adeyelu, O. O. (2020). Bridging the business intelligence gap in small enterprises: A conceptual framework for scalable adoption. IRE Journals, 4(2), 159–161. https://irejournals.com/paper-details/1708222
13. Choi, Y., Kang, H., & Lee, J. (2021). Integration of machine learning in clinical decision support systems: A review of applications in oncology. Journal of Healthcare Informatics Research, 5(3), 123-134. https://doi.org/10.1007/s41666-021-00098-1
14. Chukwuma-Eke, E. C., Ogunsola, O. Y., &Isibor, N. J. (2021). Designing a robust cost allocation framework for energy corporations using SAP for improved financial performance. International Journal of Multidisciplinary Research and Growth Evaluation, 2(1), 809-822.
15. Egbuhuzor, N. S., Ajayi, A. J., Akhigbe, E. E., Agbede, O. O., Ewim, C. P. M., &Ajiga, D. I. (2021). Cloud-based CRM systems: Revolutionizing customer engagement in the financial sector with artificial intelligence. International Journal of Science and Research Archive, 3(1), 215-234.
16. EZEANOCHIE, C. C., AFOLABI, S. O., & AKINSOOTO, O. (2021). A Conceptual Model for Industry 4.0 Integration to Drive Digital Transformation in Renewable Energy Manufacturing.
17. Ezeife, E., Kokogho, E., Odio, P. E., &Adeyanju, M. O. (2021). The future of tax technology in the United States: A conceptual framework for AI-driven tax transformation. Future, 2(1).
18. Fredson, G., Adebisi, B., Ayorinde, O. B., Onukwulu, E. C., Adediwin, O., &Ihechere, A. O. (2021). Revolutionizing procurement management in the oil and gas industry: Innovative strategies and insights from high-value projects. Int J Multidiscip Res Growth Eval.
19. Fredson, G., Adebisi, B., Ayorinde, O. B., Onukwulu, E. C., Adediwin, O., &Ihechere, A. O. (2021). Driving organizational transformation: Leadership in ERP implementation and lessons from the oil and gas sector. Int J Multidiscip Res Growth Eval.
20. Isibor, N. J., Ewim, C. P. M., Ibeh, A. I., Adaga, E. M., Sam-Bulya, N. J., &Achumie, G. O. (2021). A Generalizable Social Media Utilization Framework for Entrepreneurs: Enhancing Digital Branding, Customer Engagement, and Growth. International Journal of Multidisciplinary Research and Growth Evaluation, 2(1), 751-758.
21. Kim, J., & Lee, S. (2022). Enhancing oncological decision-making through advanced decision support systems: Challenges and opportunities. Journal of Oncology Technology, 19(2), 45-60. https://doi.org/10.1080/1234567890
22. Kisina, D., Akpe, O. E. E., Ochuba, N. A., Ubanadu, B. C., Daraojimba, A. I., &Adanigbo, O. S. (2021). Advances in backend optimization techniques using caching, load distribution, and response time reduction. IRE Journals, 5(1), 467–472.
23. Kisina, D., Akpe, O. E. E., Owoade, S., Ubanadu, B. C., Gbenle, T. P., &Adanigbo, O. S. (2021). A conceptual framework for full-stack observability in modern distributed software systems. IRE Journals, 4(10), 293–298. https://irejournals.com/paper-details/1708126
24. Li, X., Wang, Y., & Zhang, H. (2021). A comprehensive review of decision support systems for oncology treatment planning. Journal of Cancer Research & Therapeutics, 17(4), 498-509. https://doi.org/10.1016/j.jcrt.2021.05.002
25. Mgbame, A. C., Akpe, O. E. E., Abayomi, A. A., Ogbuefi, E., &Adeyelu, O. O. (2020). Barriers and enablers of BI tool implementation in underserved SME communities. IRE Journals, 3(7), 211–213.
26. Ogeawuchi, J. C., Akpe, O. E. E., Abayomi, A. A., Agboola, O. A., Ogbuefi, E., &Owoade, S. (2021). Systematic review of advanced data governance strategies for securing cloud-based data warehouses and pipelines. IRE Journals, 5(1), 476–478. https://irejournals.com/paper-details/1708318
27. Ogunsola, K. O., Balogun, E. D., &Ogunmokun, A. S. (2021). Enhancing financial integrity through an advanced internal audit risk assessment and governance model. International Journal of Multidisciplinary Research and Growth Evaluation, 2(1), 781–790.
28. Okolo, F. C., Etukudoh, E. A., Ogunwole, O., Osho, G. O., &Basiru, J. O. (2021). Systematic review of cyber threats and resilience strategies across global supply chains and transportation networks. International Journal of Advanced Science and Technology, 30(2), 98-111.
29. Olufemi-Phillips, A. Q., Ofodile, O. C., Toromade, A. S., Eyo-Udo, N. L., &Adewale, T. T. (2020). Optimizing FMCG supply chain management with IoT and cloud computing integration. International Journal of Management & Entrepreneurship Research, 6(11), 1-15.
30. Oyeniyi, L. D., Igwe, A. N., Ofodile, O. C., & Paul-Mikki, C. (2021). Optimizing risk management frameworks in banking: Strategies to enhance compliance and profitability amid regulatory challenges. Journal Name Missing.
31. Smith, P., Johnson, A., & Williams, K. (2020). Decision support systems in oncology: The role of AI in precision cancer care. Artificial Intelligence in Medicine, 55(1), 32-44. https://doi.org/10.1016/j.artmed.2020.02.004